Metformin decreased serum IGF-1, omentin, insulin, C-peptide, and leptinMetformin decreased tumor phospho-Akt, phospho-rpS6, phospho-ERK1/2 but did not change levels of Ki-67, phospho-ACC or caspase-3. Here, ITLN1 is linked to neoplasm.